On October 7, the Nasdaq Listing and Hearing Review Council affirmed a decision by the Nasdaq Hearing Panel to delist the Company's securities, based on a failure to meet the minimum bid price requirement, without having to decide on the issue of "public

Core Viewpoint - Femto Technologies Inc. has been affirmed for delisting from the Nasdaq Stock Market due to non-compliance with the Minimum Bid Price requirement, as determined by the Nasdaq Listing and Hearing Review Council [1][2] Group 1: Delisting Decision - The Nasdaq Listing and Hearing Review Council upheld the decision of the Nasdaq Hearing Panel to delist Femto's securities based on technical reasons related to the company's failure to meet the Minimum Bid Price requirement [2] - The Council indicated that the violation of the Bid Price Rule was sufficient grounds for the delisting, without needing to assess public interest considerations [2] Group 2: Future Actions - The company is contemplating a request for the Nasdaq Board of Directors to review the Council's decision, as permitted under Nasdaq Rule 5825 [2] - Femto may also pursue a review with the Securities and Exchange Commission and federal courts, while exploring listing options on other stock exchanges [3] Group 3: Operational Continuity - Despite the delisting, the company is committed to executing its recovery plan aimed at improving its capital structure and will continue its research and development activities [3] - Femto plans to promote sales of its products as scheduled, indicating ongoing operational efforts [3] Group 4: Company Overview - Femto Technologies Inc. is a femtech company focused on wellness technology, emphasizing AI-driven solutions to enhance well-being through innovative product development [4]